相关实验视频
Updated: Feb 18, 2026
06:01
Prion Safety Laboratory Swipe Test
Published on: February 14, 2025
1.4K
49岁女性的快速进展的脑病变:克鲁茨菲尔特-雅各布病
Anupama Ancha1, Jyothi R Patri2,3
1Department of Gastroenterology, Baylor Scott & White Medical Center, Temple, USA.
Cureus
|February 17, 2026
概括
克鲁茨菲尔特-雅各布病 (CJD) 是一种罕见的神经系统疾病. 这一案例突出了CJD作为快速脑病变的关键差异诊断,强调了早期的子测试.
科学领域:
- 神经学 神经学
- 子疾病是子疾病.
背景情况:
- 克鲁茨菲尔特-雅各布病 (CJD) 是一种罕见的,快速进展的神经退行性疾病.
- 由于非特异性的初始症状和模仿其他疾病,早期诊断具有挑战性.
研究的目的:
- 介绍一个最初被误诊为转化障碍的CJD病例.
- 强调在快速进展性脑病变的差异诊断中考虑CJD的重要性.
主要方法:
- 一个49岁的女性病例报告,病情迅速下降.
- 对tau和14-3-3蛋白质进行脑脊液分析.
- 专业的子研究中心的第二意见确认.
主要成果:
- 最初的检查结果并不显著;患者发烧.
- 脑脊髓液分析显示,TAU和14-3-3蛋白的含量较高.
- 证实了CJD,通过负面的瘤性抗体测试.
结论:
- 应考虑在患有渐进性脑病变,缺氧,视觉变化和认知衰退的患者中考虑CJD.
- 及时进行子测试对于准确诊断和排除可治疗疾病至关重要.
- 这一案例强调了在诊断罕见的神经疾病时需要保持警.
相关概念视频
01:26Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
01:22Alzheimer's Disease: Treatment
1.0K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.0K